Characterization of Zika virus binding and enhancement potential of a large panel of flavivirus murine monoclonal antibodies

Virology

Volumn 508, Issue , 2017, Pages 1-6

  Willis, Elinor ^a,b   Hensley, Scott E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antibody; Antibody mediated enhancement; Flavivirus; Zika virus

Indexed keywords

MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN; WEST NILE VIRUS ANTIGEN; VIRUS ANTIBODY;

ARTICLE; BINDING ASSAY; CONTROLLED STUDY; CROSS REACTION; DENGUE VIRUS; FLAVIVIRUS; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IN VITRO STUDY; INFECTION RISK; K-562 CELL LINE; MOUSE; MURINE; NONHUMAN; VIRAL PHENOMENA AND FUNCTIONS; VIRUS ATTACHMENT; VIRUS ENHANCEMENT; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN; WEST NILE VIRUS; ZIKA FEVER; ZIKA VIRUS; ANIMAL; FLAVIVIRUS INFECTION; IMMUNOLOGY; VIROLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CROSS REACTIONS; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; HUMANS; MICE; VIRAL ENVELOPE PROTEINS; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85019000067     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2017.04.031     Document Type: Article

References (43)

1. Balsitis, S.J., Williams, K.L., Lachica, R., Flores, D., Kyle, J.L., Mehlhop, E., Johnson, S., Diamond, M.S., Beatty, P.R., Harris, E., Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog., 6, 2010, e1000790.
2. Barba-Spaeth, G., Dejnirattisai, W., Rouvinski, A., Vaney, M.C., Medits, I., Sharma, A., Simon-Loriere, E., Sakuntabhai, A., Cao-Lormeau, V.M., Haouz, A., England, P., Stiasny, K., Mongkolsapaya, J., Heinz, F.X., Screaton, G.R., Rey, F.A., Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature 536 (2016), 48–53.
3. Bardina, S.V., Bunduc, P., Tripathi, S., Duehr, J., Frere, J.J., Brown, J.A., Nachbagauer, R., Foster, G.A., Krysztof, D., Tortorella, D., Stramer, S.L., Garcia-Sastre, A., Krammer, F., Lim, J.K., Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science, 2017.
4. Bearcroft, W.G., Zika virus infection experimentally induced in a human volunteer. Trans. R. Soc. Trop. Med. Hyg. 50 (1956), 442–448.
5. Beatty, P.R., Puerta-Guardo, H., Killingbeck, S.S., Glasner, D.R., Hopkins, K., Harris, E., Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci. Transl. Med., 7, 2015, 304ra141.
6. Brasil, P., Pereira, J.P. Jr., Moreira, M.E., Ribeiro Nogueira, R.M., Damasceno, L., Wakimoto, M., Rabello, R.S., Valderramos, S.G., Halai, U.A., Salles, T.S., Zin, A.A., Horovitz, D., Daltro, P., Boechat, M., Raja Gabaglia, C., Carvalho de Sequeira, P., Pilotto, J.H., Medialdea-Carrera, R., Cotrim da Cunha, D., Abreu de Carvalho, L.M., Pone, M., Machado Siqueira, A., Calvet, G.A., Rodrigues Baiao, A.E., Neves, E.S., Nassar de Carvalho, P.R., Hasue, R.H., Marschik, P.B., Einspieler, C., Janzen, C., Cherry, J.D., Bispo de Filippis, A.M., Nielsen-Saines, K., Zika Virus Infection in Pregnant Women in Rio de Janeiro. N. Engl. J. Med. 375 (2016), 2321–2334.
7. Brien, J.D., Austin, S.K., Sukupolvi-Petty, S., O'Brien, K.M., Johnson, S., Fremont, D.H., Diamond, M.S., Genotype-specific neutralization and protection by antibodies against dengue virus type 3. J. Virol. 84 (2010), 10630–10643.
8. Cao-Lormeau, V.M., Blake, A., Mons, S., Lastere, S., Roche, C., Vanhomwegen, J., Dub, T., Baudouin, L., Teissier, A., Larre, P., Vial, A.L., Decam, C., Choumet, V., Halstead, S.K., Willison, H.J., Musset, L., Manuguerra, J.C., Despres, P., Fournier, E., Mallet, H.P., Musso, D., Fontanet, A., Neil, J., Ghawche, F., Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387 (2016), 1531–1539.
9. Carteaux, G., Maquart, M., Bedet, A., Contou, D., Brugieres, P., Fourati, S., Cleret de Langavant, L., de Broucker, T., Brun-Buisson, C., Leparc-Goffart, I., Mekontso Dessap, A., Zika Virus associated with meningoencephalitis. N, Engl. J. Med. 374 (2016), 1595–1596.
10. Charles, A.S., Christofferson, R.C., Utility of a dengue-derived monoclonal antibody to enhance zika infection in vitro. PLoS Curr., 2016, 8.
11. Crill, W.D., Chang, G.J., Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J. Virol. 78 (2004), 13975–13986.
12. Dai, L., Song, J., Lu, X., Deng, Y.Q., Musyoki, A.M., Cheng, H., Zhang, Y., Yuan, Y., Song, H., Haywood, J., Xiao, H., Yan, J., Shi, Y., Qin, C.F., Qi, J., Gao, G.F., Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody. Cell Host Microbe 19 (2016), 696–704.
13. Dejnirattisai, W., Supasa, P., Wongwiwat, W., Rouvinski, A., Barba-Spaeth, G., Duangchinda, T., Sakuntabhai, A., Cao-Lormeau, V.M., Malasit, P., Rey, F.A., Mongkolsapaya, J., Screaton, G.R., Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat. Immunol. 17 (2016), 1102–1108.
14. Diamond, M.S., Pierson, T.C., Molecular insight into dengue virus pathogenesis and its implications for disease control. Cell 162 (2015), 488–492.
15. Dick, G.W., Kitchen, S.F., Haddow, A.J., Zika virus. I. Isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 46 (1952), 509–520.
16. Fauci, A.S., Morens, D.M., Zika virus in the americas–yet another arbovirus threat. N. Engl. J. Med. 374 (2016), 601–604.
17. Gentry, M.K., Henchal, E.A., McCown, J.M., Brandt, W.E., Dalrymple, J.M., Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies. Am. J. Trop. Med. Hyg. 31 (1982), 548–555.
18. Goncalvez, A.P., Engle, R.E., St Claire, M., Purcell, R.H., Lai, C.J., Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proc. Natl. Acad. Sci. USA 104 (2007), 9422–9427.
19. Halstead, S.B., Neutralization and antibody-dependent enhancement of dengue viruses. Adv. Virus Res. 60 (2003), 421–467.
20. Halstead, S.B., 2015. Pathogenesis of Dengue: Dawn of a New Era. F1000Res 4.
21. Halstead, S.B., O'Rourke, E.J., Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265 (1977), 739–741.
22. Hazin, A.N., Poretti, A., Turchi Martelli, C.M., Huisman, T.A., Microcephaly Epidemic Research, G., Di Cavalcanti Souza Cruz, D., Tenorio, M., van der Linden, A., Pena, L.J., Brito, C., Gil, L.H., de Barros Miranda-Filho, D., Marques, E.T., Alves, J.G., Computed tomographic findings in microcephaly associated with Zika Virus. New Engl. J. Med. 374 (2016), 2193–2195.
23. Henchal, E.A., Gentry, M.K., McCown, J.M., Brandt, W.E., Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am. J. Trop. Med. Hyg. 31 (1982), 830–836.
24. Hennessey, M., Fischer, M., Staples, J.E., 2016. Zika Virus Spreads to New Areas - Region of the Americas, May 2015-January 2016. MMWR. Morbidity and mortality weekly report 65, 55-58.
25. Lubeck, M.D., Steplewski, Z., Baglia, F., Klein, M.H., Dorrington, K.J., Koprowski, H., The interaction of murine IgG subclass proteins with human monocyte Fc receptors. J. Immunol. 135 (1985), 1299–1304.
26. Messina, J.P., Brady, O.J., Scott, T.W., Zou, C., Pigott, D.M., Duda, K.A., Bhatt, S., Katzelnick, L., Howes, R.E., Battle, K.E., Simmons, C.P., Hay, S.I., Global spread of dengue virus types: mapping the 70 year history. Trends Microbiol. 22 (2014), 138–146.
27. Mlakar, J., Korva, M., Tul, N., Popovic, M., Poljsak-Prijatelj, M., Mraz, J., Kolenc, M., Resman Rus, K., Vesnaver Vipotnik, T., Fabjan Vodusek, V., Vizjak, A., Pizem, J., Petrovec, M., Avsic Zupanc, T., Zika Virus associated with microcephaly. N. Engl. J. Med. 374 (2016), 951–958.
28. Oehler, E., Watrin, L., Larre, P., Leparc-Goffart, I., Lastere, S., Valour, F., Baudouin, L., Mallet, H., Musso, D., Ghawche, F., Zika virus infection complicated by Guillain-Barre syndrome–case report, French Polynesia, December 2013. Eur. Surveill.: Bull. Eur. sur Les. Mal. Transm. = Eur. Commun. Dis. Bull., 2014, 19.
29. Oliphant, T., Engle, M., Nybakken, G.E., Doane, C., Johnson, S., Huang, L., Gorlatov, S., Mehlhop, E., Marri, A., Chung, K.M., Ebel, G.D., Kramer, L.D., Fremont, D.H., Diamond, M.S., Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat. Med. 11 (2005), 522–530.
30. Oliphant, T., Nybakken, G.E., Engle, M., Xu, Q., Nelson, C.A., Sukupolvi-Petty, S., Marri, A., Lachmi, B.E., Olshevsky, U., Fremont, D.H., Pierson, T.C., Diamond, M.S., Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. J. Virol. 80 (2006), 12149–12159.
31. Paul, L.M., Carlin, E.R., Jenkins, M.M., Tan, A.L., Barcellona, C.M., Nicholson, C.O., Michael, S.F., Isern, S., Dengue virus antibodies enhance Zika virus infection. Clin. Transl. Immunol., 5, 2016, e117.
32. Priyamvada, L., Quicke, K.M., Hudson, W.H., Onlamoon, N., Sewatanon, J., Edupuganti, S., Pattanapanyasat, K., Chokephaibulkit, K., Mulligan, M.J., Wilson, P.C., Ahmed, R., Suthar, M.S., Wrammert, J., Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc. Natl. Acad. Sci. USA 113 (2016), 7852–7857.
33. Schmid, M.A., Diamond, M.S., Harris, E., Dendritic cells in dengue virus infection: targets of virus replication and mediators of immunity. Front. Immunol., 5, 2014, 647.
34. Shrestha, B., Brien, J.D., Sukupolvi-Petty, S., Austin, S.K., Edeling, M.A., Kim, T., O'Brien, K.M., Nelson, C.A., Johnson, S., Fremont, D.H., Diamond, M.S., The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. PLoS Pathog., 6, 2010, e1000823.
35. Simpson, D.I., Zika virus infection in man. Trans. R. Soc. Trop. Med. Hyg. 58 (1964), 335–338.
36. Stettler, K., Beltramello, M., Espinosa, D.A., Graham, V., Cassotta, A., Bianchi, S., Vanzetta, F., Minola, A., Jaconi, S., Mele, F., Foglierini, M., Pedotti, M., Simonelli, L., Dowall, S., Atkinson, B., Percivalle, E., Simmons, C.P., Varani, L., Blum, J., Baldanti, F., Cameroni, E., Hewson, R., Harris, E., Lanzavecchia, A., Sallusto, F., Corti, D., Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353 (2016), 823–826.
37. Stiasny, K., Kiermayr, S., Holzmann, H., Heinz, F.X., Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J. Virol. 80 (2006), 9557–9568.
38. Sukupolvi-Petty, S., Brien, J.D., Austin, S.K., Shrestha, B., Swayne, S., Kahle, K., Doranz, B.J., Johnson, S., Pierson, T.C., Fremont, D.H., Diamond, M.S., Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection. J. Virol. 87 (2013), 8826–8842.
39. Vieira, M.A., Romano, A.P., Borba, A.S., Silva, E.V., Chiang, J.O., Eulalio, K.D., Azevedo, R.S., Rodrigues, S.G., Almeida-Neto, W.S., Vasconcelos, P.F., West Nile Virus Encephalitis: the first human case recorded in Brazil. Am. J. Trop. Med Hyg. 93 (2015), 377–379.
40. Wang, T.T., Sewatanon, J., Memoli, M.J., Wrammert, J., Bournazos, S., Bhaumik, S.K., Pinsky, B.A., Chokephaibulkit, K., Onlamoon, N., Pattanapanyasat, K., Taubenberger, J.K., Ahmed, R., Ravetch, J.V., IgG antibodies to dengue enhanced for FcgammaRIIIA binding determine disease severity. Science 355 (2017), 395–398.
41. Whitehead, S.S., Blaney, J.E., Durbin, A.P., Murphy, B.R., Prospects for a dengue virus vaccine. Nat. Rev. Microbiol 5 (2007), 518–528.
42. Zellweger, R.M., Prestwood, T.R., Shresta, S., Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe 7 (2010), 128–139.
43. Zhao, H., Fernandez, E., Dowd, K.A., Speer, S.D., Platt, D.J., Gorman, M.J., Govero, J., Nelson, C.A., Pierson, T.C., Diamond, M.S., Fremont, D.H., Structural basis of Zika virus-specific antibody protection. Cell 166 (2016), 1016–1027.